Literature DB >> 26155971

Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan.

Tomomi Egawa-Takata1, Yutaka Ueda2, Akiko Morimoto1, Yusuke Tanaka1, Shinya Matsuzaki1, Eiji Kobayashi1, Kiyoshi Yoshino1, Masayuki Sekine3, Takayuki Enomoto3, Tadashi Kimura1.   

Abstract

BACKGROUND: Most adolescents in Japan have recently been refraining from receiving the human papillomavirus (HPV) vaccine, following media reports of adverse medical events surrounding the vaccination and suspension of the Japanese governmental recommendation. We have previously reported that HPV vaccination of young girls is heavily influenced by guidance from their physicians concerning the vaccine and by the knowledge and attitude of the girls' mothers towards cervical cancer. However, it has been unclear as to how the obstetricians and gynecologists were themselves affected by the negative media reports.
METHODS: A questionnaire, including questions about their working status, attitudes toward HPV vaccination and about cervical cancer, and the HPV vaccination status of their daughters, was posted to obstetricians and gynecologists.
RESULTS: None of the daughters of the responding obstetrician and gynecologists received the HPV vaccination after the announced suspension of the governmental recommendation for the vaccine. The number who received the HPV vaccine in the 6th to 9th grade in 2014 was significantly lower than those in 2012 (p = 0.012). However, 64.7 % of the responders whose daughters were eligible and in the 6th to 12th grade still intended to vaccinate their daughters in the future. Of the responders, 65 % also intended to recommend vaccination to their teenage patients.
CONCLUSIONS: Our study revealed that obstetricians and gynecologists, like the general population, were negatively influenced by media reports of the adverse effect of the HPV vaccine and the suspension of the governmental recommendation. However, their intention to vaccinate their daughters was much higher than that of the general population. Restart of the governmental recommendation for HPV vaccines and better education about the HPV vaccine, including its adverse effects, and about cervical cancer and cervical cancer screening, are strongly recommended, for both the general public and for doctors, for improved prevention of cervical cancer.

Entities:  

Keywords:  Gynecologist; Human papillomavirus; Japan; Obstetrician; Questionnaire; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 26155971     DOI: 10.1007/s10147-015-0869-5

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  8 in total

1.  Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Authors:  Matti Lehtinen; Jorma Paavonen; Cosette M Wheeler; Unnop Jaisamrarn; Suzanne M Garland; Xavier Castellsagué; S Rachel Skinner; Dan Apter; Paulo Naud; Jorge Salmerón; Song-Nan Chow; Henry Kitchener; Júlio C Teixeira; James Hedrick; Genara Limson; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; Newton S De Carvalho; Maria Julieta V Germar; Klaus Peters; Adrian Mindel; Philippe De Sutter; F Xavier Bosch; Marie-Pierre David; Dominique Descamps; Frank Struyf; Gary Dubin
Journal:  Lancet Oncol       Date:  2011-11-08       Impact factor: 41.316

2.  Japan's failure to vaccinate girls against human papillomavirus.

Authors:  Yutaka Ueda; Takayuki Enomoto; Masayuki Sekine; Tomomi Egawa-Takata; Akiko Morimoto; Tadashi Kimura
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

3.  Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010.

Authors:  Paul M Darden; David M Thompson; James R Roberts; Jessica J Hale; Charlene Pope; Monique Naifeh; Robert M Jacobson
Journal:  Pediatrics       Date:  2013-03-18       Impact factor: 7.124

4.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

5.  Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.

Authors:  Barbara A Slade; Laura Leidel; Claudia Vellozzi; Emily Jane Woo; Wei Hua; Andrea Sutherland; Hector S Izurieta; Robert Ball; Nancy Miller; M Miles Braun; Lauri E Markowitz; John Iskander
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

6.  Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.

Authors:  Akiko Morimoto; Yutaka Ueda; Tomomi Egawa-Takata; Asami Yagi; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hideharu Kanzaki; Hidekatsu Nakai; Masaki Mandai; Kiyoshi Yoshino; Masami Fujita; Tadashi Kimura; Junko Saito; Tomotaka Sobue; Nobumichi Nishikawa; Masayuki Sekine; Takayuki Enomoto; Yorihiko Horikoshi; Tetsu Takagi
Journal:  Int J Clin Oncol       Date:  2014-07-09       Impact factor: 3.402

7.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

Review 8.  Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.

Authors:  Beibei Lu; Ambuj Kumar; Xavier Castellsagué; Anna R Giuliano
Journal:  BMC Infect Dis       Date:  2011-01-12       Impact factor: 3.090

  8 in total
  5 in total

1.  Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): A scoping review.

Authors:  Diviya Santhanes; Che Pui Wong; Yan Ye Yap; Saw Pui San; Nathorn Chaiyakunapruk; Tahir Mehmood Khan
Journal:  Hum Vaccin Immunother       Date:  2017-11-17       Impact factor: 3.452

2.  Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: A systematic review and meta-analysis.

Authors:  Diviya Santhanes; Che Pui Yong; Yan Ye Yap; Pui San Saw; Nathorn Chaiyakunapruk; Tahir Mehmood Khan
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

3.  HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine.

Authors:  Masaaki Sawada; Yutaka Ueda; Asami Yagi; Akiko Morimoto; Ruriko Nakae; Reisa Kakubari; Hazuki Abe; Tomomi Egawa-Takata; Tadashi Iwamiya; Shinya Matsuzaki; Eiji Kobayashi; Kiyoshi Yoshino; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2017-10-06       Impact factor: 3.402

4.  Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine.

Authors:  Yoshikazu Nagase; Yutaka Ueda; Hazuki Abe; Asami Yagi; Masaaki Sawada; Satoshi Nakagawa; Kosuke Hiramatsu; Tomomi Egawa-Takata; Shinya Matsuzaki; Eiji Kobayashi; Toshihiro Kimura; Tadashi Kimura
Journal:  Hum Vaccin Immunother       Date:  2020-01-16       Impact factor: 3.452

5.  Japanese physicians' attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines.

Authors:  Tomohiro Katsuta; Charlotte A Moser; Paul A Offit; Kristen A Feemster
Journal:  Papillomavirus Res       Date:  2019-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.